Phase I/II Study of ZD6474 (Vandetanib) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
Phase of Trial: Phase I/II
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Vandetanib (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 15 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 11 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 21 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Mar 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History